首页|吲哚布芬或阿司匹林分别联合氯吡格雷和替罗非班在急性心肌梗死PCI后患者中的应用对比

吲哚布芬或阿司匹林分别联合氯吡格雷和替罗非班在急性心肌梗死PCI后患者中的应用对比

扫码查看
目的 对比吲哚布芬或阿司匹林分别联合氯吡格雷和替罗非班在急性心肌梗死(acute myocardial infarction,AMI)患者经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后的应用效果。方法 回顾性分析平煤神马医疗集团总医院2021年10月至2023年9月收治的90例行PCI治疗的AMI患者资料,根据PCI后治疗方案不同将其分为对照组(n=49)和观察组(n=41),对照组采用阿司匹林联合氯吡格雷、替罗非班治疗,观察组采用吲哚布芬联合氯毗格雷、替罗非班治疗。比较两组血小板功能(血小板黏附率、血小板聚集率)、血清炎性因子[C反应蛋白(C-reactive protein,CRP)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白介素 6(interleukin-6,IL-6)]、心功能[左室射血分数(left ventricular ejection fraction,LVEF)、左室舒张末期内径(left ventricular end dias-tolic diameter,LVEDD)],统计患者不良反应[胃肠道反应(恶心、呕吐、腹痛、腹胀)、过敏反应、出血]发生情况。结果 治疗后,两组血小板黏附率、聚集率有所降低,差异有统计学意义(P<0。05),而组间比较差异无统计学意义(P>0。05)。治疗后,两组CRP、TNF-α、IL-6有所降低,差异有统计学意义(P<0。05),而组间比较差异无统计学意义(P>0。05)。治疗后,两组LVEF有所升高,LVEDD有所降低,差异有统计学意义(P<0。05),而组间比较差异无统计学意义(P>0。05)。观察组胃肠道反应发生率(12。20%)低于对照组(30。61%),差异有统计学意义(x2=4。381,P=0。036)。结论 吲哚布芬或阿司匹林分别联合氯吡格雷和替罗非班在AMI患者PCI后的治疗效果相当,均能抑制患者血小板活性,缓解炎症,改善心功能,而吲哚布芬安全性更高。
Comparison of the application of indobufen or aspirin combined with clopidogrel and tirofiban in patients with acute myocardial infarction after PCI
Objective To compare the application effects of indobufen or aspirin combined with clopidogrel and tirofiban in patients with acute myocardial infarction(AMI)after PCI.Methods A retrospective analysis was conducted on the data of 90 AMI patients treated with PCI at Pingmei Shenma Medical General Hospital from October 2021 to September 2023.According to different post PCI treatment plans,they were divided into a control group(n=49)and an observation group(n=41).The control group was treated with aspirin combined with clopidogrel and tirofiban,while the observation group was treated with in-dobufen combined with clopidogrel and tirofiban.The platelet function(platelet adhesion rate,platelet aggregation rate),ser-um inflammatory factors[C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)],and cardiac function[left ventricular ejection fraction(LVEF),left ventricular end diastolic diameter(LVEDD)]were compared between two groups,and record the incidence of adverse reactions[gastrointestinal reactions(nausea,vomiting,abdominal pain,bloating),allergic reactions,bleeding]in patients.Results After treatment,the platelet adhesion and aggregation rates in both groups decreased,and the difference was statistically significant(P<0.05),while there was no significant difference between the groups(P>0.05).After treatment,CRP,TNF-α,and IL-6 in both groups significantly decreased slightly,and the difference was statistically significant(P<0.05),while there was no significant difference between the groups(P>0.05).After treatment,LVEF increased and LVEDD decreased in both groups,and the difference was statisti-cally significant(P<0.05),while there was no significant difference between the groups(P>0.05).The incidence of gas-trointestinal reactions in the observation group(12.20%)was lower than that in the control group(30.61%),and the differ-ence was statistically significant(x2=4.381,P=0.036).Conclusion Indobufen or aspirin combined with clopidogrel and tirofiban have similar therapeutic effects in AMI patients after PCI,both of which can inhibit platelet activity,alleviate inflam-mation,and improve heart function.Meanwhile indobufen is safer.

Acute myocardial infarctionPercutaneous coronary interventionIndobufenAspirinClopidogrelTirofiban

杨炫露、侯彩娜

展开 >

平煤神马医疗集团总医院药品调剂科,河南平顶山 467000

平煤神马医疗集团总医院心血管内科,河南平顶山 467000

急性心肌梗死 经皮冠状动脉介入术 吲哚布芬 阿司匹林 氯吡格雷 替罗非班

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(19)